Past Events

  • Read more: Developments and Implications of New Legislation on Follow-on Biologics

    Developments and Implications of New Legislation on Follow-on Biologics

    This panel examined current legislative debates concerning the development of regulatory approval processes for follow-on biologics, or large molecule drugs that are created by biological processes, as opposed to medicines created by chemical formulas. The panelists were Peter Hutt, Senior Counsel at Covington & Burling LLP and Lecturer on Law at Harvard Law School, and…

  • Read more: Health Law Workshop: Theodore Ruger

    Health Law Workshop: Theodore Ruger

    Presentation Download Theodore Ruger‘s paper: The Thompsonian Movement and the Structures of American Health Law

  • Read more: Health Metrics Workshop

    Health Metrics Workshop

    Over two days in November, the Center convened leading thinkers in the area of health metrics evaluation to develop consensus on an appropriate set of metrics and tools for evaluating the impact of innovation on global health. The workshop brought together 30 distinguished scholars, medical researchers, and practitioners with experience in law, economics, philosophy, business,…

  • Read more: Medical Prize Funds

    Medical Prize Funds

    An Alternative Reward Mechanism for Medical Innovation Patenting and other rewards that rely on protected markets to encourage research investment in medical technology do not always provide the right incentives needed to optimize public health. In recent years, a number of proposals have focused on replacing or supplementing the patent system and related incentives with…

  • Read more: Comparative Models of Health Care Reform

    Comparative Models of Health Care Reform

    This colloquium brought together specialists on a group of model states and countries to discuss relevant health care systems, their successes and limitations, and their potential application to the reform of health care in the United States. The event aimed to interpret the U.S. reform effort in the context of the global system and to…

  • Read more: Electronic Health Records and Medical Liability
    Oct 27

    Electronic Health Records and Medical Liability

    The American Recovery and Reinvestment Act of 2009 promises to trigger an explosion in the use of electronic health records through direct payments to health providers. While the privacy concerns related to electronic health records (EHR) have been discussed at length, little attention has been given to the impact EHR might have on a provider’s…

  • Read more: Health Law, HIV/AIDS Policy and Disability Rights in the New Administration

    Health Law, HIV/AIDS Policy and Disability Rights in the New Administration

    Jeff Crowley, the White House Director of National AIDS Policy and Senior Advisor on Disability Policy, visited Harvard Law School to speak about the Obama Administration’s agendas for health reform, developing a national AIDS strategy, addressing health disparities, and disability rights. Mr. Crowley addressed the issue of health reform, noting that it dominates the Obama…

  • Read more: When Medical Care Compromises Financial Health
    Sep 22

    When Medical Care Compromises Financial Health

    Universal health insurance may be on the horizon, but a growing body of empirical research has shown that, even for those who enjoy health insurance, medical crises can push families to the financial brink, causing them to load up credit cards, miss work, forgo additional care, lose their homes to foreclosures, and even declare bankruptcy….

  • Read more: Health Law Workshop: Joseph Doyle
    Feb 11

    Health Law Workshop: Joseph Doyle

    Presentation Download Joseph Doyle‘s paper: Returns to Physician Human Capital: Analyzing Patients Randomized to Physician Teams

  • Read more: Pharmaceutical Research, Development, and Markets
    Jun 12

    Pharmaceutical Research, Development, and Markets

    Amidst this larger debate about drug prices and pharmaceutical innovation, there is a growing consensus of a need for reform in the industry and how it is regulated. The substance of the necessary reforms remains subject to great debate, however, and the policies chosen by Congress are likely to have significant consequences for the public….